FeesSafety
Pluang+

Apollo Silver's Calico Project shows strong economics with $737M NPV and 25% IRR at $55/oz silver

Market News
29 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
Apollo Silver's Calico Project shows strong economics with $737M NPV and 25% IRR at $55/oz silver

Apollo Silver Corp. announced a positive Preliminary Economic Assessment (PEA) for its Calico Silver Project in California, revealing an after-tax net present value (NPV) of $737 million and an internal rate of return (IRR) of 25% at a silver price of $55 per ounce. The project plans a 15-year open-pit mine producing an average of 5 million ounces of silver annually, with initial capital costs of $633 million and a payback period of 3 years. The PEA includes updated mineral resources and highlights opportunities for further exploration, particularly at the Langtry deposit. Next steps involve de-risking through environmental studies, securing water and power, and advancing towards a prefeasibility study.

Apollo Silver's Calico project is the subject of this update. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 29, 2026 17:51 WIB: out of 83 priced US stocks, 22 rose and 58 fell. Notable movers include AGI at USD 29.84 (-5.76%), HYMC at USD 16.67 (-4.42%), and FMC at USD 4.66 (+4.25%) with a typical hold time of 64 days and order activity skewed 73% Sell / 27% Buy.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App